Literature DB >> 14619482

[Concentration of 5-FU after hepatic artery infusion chemotherapy for liver metastases of colorectal cancer].

Shoji Maruyama1, Masayuki Ando, Takaho Watayo.   

Abstract

AIM: Hepatic artery infusion chemotherapy (HAI) using 5-FU is a good method of treating patients with liver metastases from colorectal cancer. We investigated the toxicity and the response in relation to the concentration of 5-FU after HAI, and examined various factors that would have an effect on the 5-FU concentration.
RESULTS: The mean 5-FU concentration was 480 ng/ml. The most frequent complication of HAI was anorexia. Three of 14 patients suffered from grade 2 or 1 anorexia. The 5-FU concentration of these patients was higher (1,010, 721, 642 ng/ml) than that of the others. The response rate of HAI was 36%. The 5-FU concentration of responders tended to be lower than that of non-responders. None of the following was related to the 5-FU concentration: whether or not the gallbladder was resected, whether or not co-lateral blood flow was recognized, or the volume of the patients' liver.
CONCLUSION: 5-FU concentration after HAI has some effect on anti-tumor response and gastrointestinal toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14619482

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  5 in total

1.  Pilot study of hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for patients with postoperative liver metastases from pancreatic cancer.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Hirohisa Kitagawa; Seisho Sakai; Isamu Makino; Hironori Hayashi; Katsunobu Oyama; Hisatoshi Nakagawara; Hideto Fujita; Ichiro Onishi; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Takashi Tani; Takashi Fujimura; Wataru Koda; Tetsuya Minami; Yasuji Ryu; Junichiro Sanada; Toshifumi Gabata; Osamu Matsui
Journal:  Exp Ther Med       Date:  2011-01-12       Impact factor: 2.447

2.  Hepatic arterial infusion chemotherapy for post-operative liver metastases from pancreatic cancer in a patient with leukocytopenia: A case report.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Hirohisa Kitagawa; Seisho Sakai; Isamu Makino; Hironori Hayashi; Hisatoshi Nakagawara; Ichiro Onishi; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Takashi Tani; Takashi Fujimura; Masato Kayahara; Wataru Koda; Tetsuya Minami; Yasuharu Ryu; Junichiro Sanada; Osamu Matsui
Journal:  Exp Ther Med       Date:  2010-09-29       Impact factor: 2.447

3.  Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties.

Authors:  Ngoc Bich Vu; Tam Thanh Nguyen; Long Cong-Duy Tran; Cong Dinh Do; Bac Hoang Nguyen; Ngoc Kim Phan; Phuc Van Pham
Journal:  Cytotechnology       Date:  2012-10-27       Impact factor: 2.058

4.  Hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil or oral S-1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer.

Authors:  Hidehiro Tajima; Hirohisa Kitagawa; Tomoya Tsukada; Koichi Okamoto; Shin-Ichi Nakanuma; Seisho Sakai; Isamu Makino; Hiroyuki Furukawa; Hironori Hayashi; Katsunobu Oyama; Masafumi Inokuchi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hiroshi Itoh; Hideto Fujita; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Takashi Fujimura; Tetsuo Ohta; Wataru Koda; Tetsuya Minami; Yasuji Ryu; Junichiro Sanada; Toshifumi Gabata; Osamu Matsui; Yoshimichi Sai
Journal:  Mol Clin Oncol       Date:  2013-07-23

5.  Hepatic Arterial Infusion Chemotherapy for Liver Metastases Following Standard Chemotherapy for Pancreatic Cancer.

Authors:  Shinya Endo; Shinya Kawaguchi; Shuzo Terada; Naofumi Shirane
Journal:  Intern Med       Date:  2020-09-19       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.